StocktoriaGenprex, Inc. GNPX
Nasdaq · XNAS · stock · Pharmaceutical Preparations
Chart by TradingView
3/9
Piotroski F — financial health
—
Altman Z″ — distress risk
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | — | $0 | $0 | $0 | $0 |
| Operating income | -$15.5M | -$21.2M | -$31.1M | -$23.8M | -$20.7M |
| Net income | -$16.2M | -$21.1M | -$30.9M | -$23.7M | -$20.7M |
| Operating cash flow | -$15.3M | -$17.9M | -$24.7M | -$17.6M | -$14.3M |
| Free cash flow | — | — | — | -$17.6M | -$14.3M |
| Total assets | $10.2M | $4.1M | $10.7M | $25.1M | $42.9M |
| Total liabilities | $2.2M | $2.5M | — | — | $1.6M |
| Shareholders' equity | $8.0M | $1.6M | $7.4M | $22.3M | $41.3M |
| Ratios | |||||
| Return on assets | -159.7% | -511.9% | -289.2% | -94.6% | -48.2% |
| Return on equity | -203.8% | -1303.0% | -416.1% | -106.6% | -50.1% |
| Current ratio | 3.84 | 0.83 | 2.31 | 7.64 | 24.69 |
Why these scores methodology →
Piotroski F-score: 3/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: n/a
Not applicable (financials/insurer or missing inputs).
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001595248 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.